These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 20567673)

  • 41. Composite osseomusculocutaneous sternum, ribs, thymus, pectoralis muscles, and skin allotransplantation model of bone marrow transplantation.
    Bozkurt M; Klimczak A; Nasir S; Zor F; Krokowicz L; Siemionow M
    Microsurgery; 2013 Jan; 33(1):43-50. PubMed ID: 22821819
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Role of Facial Vascularized Composite Allotransplantation in Burn Patients.
    Bharadia D; Sinha I; Pomahac B
    Clin Plast Surg; 2017 Oct; 44(4):857-864. PubMed ID: 28888310
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tolerance induction via mixed chimerism in vascularized composite allotransplantation: is it time for clinical application?
    Cetrulo CL; Drijkoningen T; Sachs DH
    Curr Opin Organ Transplant; 2015 Dec; 20(6):602-7. PubMed ID: 26536420
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Biomarker and surrogate development in vascularised composite allograft transplantation: Current progress and future challenges.
    Honeyman C; Stark H; Wang HC; Hester J; Issa F; Giele H
    J Plast Reconstr Aesthet Surg; 2021 Apr; 74(4):711-717. PubMed ID: 33436335
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hand transplant--a challenge in immunological management of patients.
    Moise A; Constantinescu I; Serbanescu B; Gîngu CV; Zamfirescu DG; Lascar I
    J Med Life; 2011 Aug; 4(3):287-90. PubMed ID: 22567053
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Extracorporeal photopheresis: from solid organs to face transplantation.
    Hivelin M; Siemionow M; Grimbert P; Lantieri L
    Transpl Immunol; 2009 Jul; 21(3):117-28. PubMed ID: 19409991
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A modified model of hindlimb osteomyocutaneous flap for the study of tolerance to composite tissue allografts.
    Adamson LA; Huang WC; Breidenbach WC; Rahhal D; Xu H; Huang Y; Pidwell DJ; Wei FC; Tobin G; Ildstad ST
    Microsurgery; 2007; 27(7):630-6. PubMed ID: 17868137
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Rat model of heterotopic toe allotransplantation.
    Zhu H; Xie F; Sheng L; Yu Q; Li Q
    J Surg Res; 2015 Dec; 199(2):707-17. PubMed ID: 26081004
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Chimerism and bone marrow based therapies in transplantation.
    Siemionow M; Nasir S
    Microsurgery; 2007; 27(5):510-21. PubMed ID: 17596895
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of the vascularized bone components on the survival of vascularized composite allografts.
    Chen J; Zhang D; Zhang T; Chen C; Song Y; Liu S; Su Y; Guo S
    J Surg Res; 2018 Apr; 224():132-138. PubMed ID: 29506828
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Vascularised composite allotransplants: Transplant of upper extremities and face.
    Iyer S
    Indian J Plast Surg; 2015; 48(2):111-8. PubMed ID: 26424972
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long-term acceptance of composite tissue allografts through mixed chimerism and CD28 blockade.
    Foster RD; Pham S; Li S; Aitouche A
    Transplantation; 2003 Sep; 76(6):988-94. PubMed ID: 14508367
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunodepletive anti-alpha/beta-TCR antibody in transplantation of composite tissue allografts: Cleveland Clinic research experience.
    Siemionow M; Klimczak A
    Immunotherapy; 2009 Jul; 1(4):585-98. PubMed ID: 20635989
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Intra-graft injection of tacrolimus promotes survival of vascularized composite allotransplantation.
    Olariu R; Denoyelle J; Leclère FM; Dzhonova DV; Gajanayake T; Banz Y; Hayoz M; Constantinescu M; Rieben R; Vögelin E; Taddeo A
    J Surg Res; 2017 Oct; 218():49-57. PubMed ID: 28985877
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunomodulatory Effects of Different Cellular Therapies of Bone Marrow Origin on Chimerism Induction and Maintenance Across MHC Barriers in a Face Allotransplantation Model.
    Hivelin M; Klimczak A; Cwykiel J; Sonmez E; Nasir S; Gatherwright J; Siemionow M
    Arch Immunol Ther Exp (Warsz); 2016 Aug; 64(4):299-310. PubMed ID: 26708158
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Composite tissue allotransplantation: development of a preclinical model in nonhuman primates.
    Cendales LC; Xu H; Bacher J; Eckhaus MA; Kleiner DE; Kirk AD
    Transplantation; 2005 Nov; 80(10):1447-54. PubMed ID: 16340790
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Porcine heterotopic composite tissue allograft transplantation using a large animal model for preclinical studies.
    Kuo YR; Sacks JM; Lee WP; Wu WS; Kueh NS; Yao SF; Chiang YC
    Chang Gung Med J; 2006; 29(3):268-74. PubMed ID: 16924888
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Significance of Vascular Alterations in Acute and Chronic Rejection for Vascularized Composite Allotransplantation.
    Kollar B; Kamat P; Klein HJ; Waldner M; Schweizer R; Plock JA
    J Vasc Res; 2019; 56(4):163-180. PubMed ID: 31266018
    [TBL] [Abstract][Full Text] [Related]  

  • 59. New composite tissue allograft model of vascularized bone marrow transplant: the iliac osteomyocutaneous flap.
    Nasir S; Klimczak A; Sonmez E; Bozkurt M; Gibson S; Siemionow M
    Transpl Int; 2010 Jan; 23(1):90-100. PubMed ID: 19686290
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Vascularized composite allotransplants as a mechanistic model for allograft rejection - an experimental study.
    Moris D; Wang J; Selim MA; Song M; Stempora L; Parker W; Kirk AD; Cendales LC
    Transpl Int; 2021 Mar; 34(3):572-584. PubMed ID: 33453073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.